Sacramento based Sutter Health will delay posting its third quarter financial statements until the terms of an antitrust settlement are made public.
In October, Sutter reached a preliminary agreement in an antitrust case brought by employers and later joined by California Attorney General Xavier Becerra. If approved, the settlement will resolve allegations that Sutter Health violated California’s antitrust laws by using its market power to overcharge patients and employer-funded health plans. The class members alleged Sutter Health’s inflated prices led to $756 million in overcharges, according to Bloomberg Law.
“While Sutter Health maintains its contracting practices were, and remain, in compliance with industry standards, it also believes the settlement avoids a protracted trial and years of appeals, which would not be in the best interest of its patients,” states a notice to bondholders filed by Sutter Nov. 25.
In the notice, Sutter said it is bound by court-ordered confidentiality requirements regarding the tentative agreement.
“Due to these confidentiality requirements, Sutter Health will delay posting of its third quarter financial statements and certain updated disclosure information until the court permits the sharing of the terms of the settlement,” the notice states.
A hearing on a motion for preliminary approval of the settlement is scheduled for Feb. 25, 2020, and a hearing on a motion for final approval is expected to occur in summer 2020.
Full Content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Turkey Ends Meta Investigation Over Threads and Instagram
Dec 8, 2024 by
CPI
Supreme Court to Hear CCI Petition on Amazon, Flipkart Antitrust Cases
Dec 8, 2024 by
CPI
Senators Urge Antitrust Probe Into FanDuel and DraftKings
Dec 8, 2024 by
CPI
Novo Holdings Secures EU Approval for $16.5 Billion Catalent Acquisition
Dec 8, 2024 by
CPI
US Appeals Court Upholds TikTok Divestment Law, Paving Way for Potential Ban
Dec 8, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Moats & Entrenchment
Nov 29, 2024 by
CPI
Assessing the Potential for Antitrust Moats and Trenches in the Generative AI Industry
Nov 29, 2024 by
Allison Holt, Sushrut Jain & Ashley Zhou
How SEP Hold-up Can Lead to Entrenchment
Nov 29, 2024 by
Jay Jurata, Elena Kamenir & Christie Boyden
The Role of Moats in Unlocking Economic Growth
Nov 29, 2024 by
CPI
Overcoming Moats and Entrenchment: Disruptive Innovation in Generative AI May Be More Successful than Regulation
Nov 29, 2024 by
Simon Chisholm & Charlie Whitehead